Researchers found that those with SARS-CoV-2 infections had a 63% increased risk of developing one or more cardiovascular conditions—including arrhythmias, heart inflammation, chest pain, palpitations, and hypertension—compared to those with negative tests and no documented history of SARS-CoV-2 infection. These risks were elevated regardless of whether the patient had a congenital heart defect (CHD).
Young patients with positive SARS-CoV-2 tests had a 17 percent higher risk of developing chronic kidney disease tested at stage 2 or higher, indicating mild kidney damage that still functioned well, and 35 percent higher risk of chronic kidney disease at stage 3 or higher, meaning there is mild to severe damage impacting kidney function, from one month to two years after infection.
Patients who had a positive SARS-CoV-2 test—compared to those with a negative test—had a 25 percent increased risk of developing at least one gastrointestinal symptom or disorder in the post-acute phase, and a 28 percent increased risk in the “chronic phase” from six months to two years after the SARS-CoV-2 test.